Somatic Systems Stock Fundamentals
| SMAS Stock | USD 0.0001 0.00 0.00% |
Fundamental analysis of Somatic Systems allows traders to better anticipate movements in Somatic Systems' stock price by examining its financial health and performance throughout various phases of its business cycle.
At this time, Somatic Systems' Total Revenue is comparatively stable compared to the past year. Gross Profit is likely to gain to about 90.9 K in 2026, whereas Selling General Administrative is likely to drop slightly above 312.1 K in 2026. Somatic | Select Account or Indicator | Build AI portfolio with Somatic Stock |
Somatic Systems Company Profit Margin Analysis
Somatic Systems' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Somatic Systems Profit Margin | (2.23) % |
Most of Somatic Systems' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Somatic Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Somatic Systems has a Profit Margin of -2.2256%. This is 188.32% lower than that of the Consumer Cyclical sector and 148.17% lower than that of the Personal Services industry. The profit margin for all United States stocks is 75.24% higher than that of the company.
Somatic Systems Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Somatic Systems's current stock value. Our valuation model uses many indicators to compare Somatic Systems value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Somatic Systems competition to find correlations between indicators driving Somatic Systems's intrinsic value. More Info.Somatic Systems is currently regarded as top stock in profit margin category among its peers. It also is currently regarded as top stock in operating margin category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Somatic Systems by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Somatic Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Somatic Systems' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Somatic Systems could also be used in its relative valuation, which is a method of valuing Somatic Systems by comparing valuation metrics of similar companies.Somatic Systems is currently under evaluation in profit margin category among its peers.
Somatic Fundamentals
| Profit Margin | (2.23) % | ||||
| Operating Margin | (4.97) % | ||||
| Current Valuation | 1.46 M | ||||
| Shares Outstanding | 14.6 B | ||||
| Price To Sales | 13.59 X | ||||
| Revenue | 107.42 K | ||||
| Gross Profit | 97.66 K | ||||
| EBITDA | (215.35 K) | ||||
| Net Income | (239.08 K) | ||||
| Cash And Equivalents | 7.67 K | ||||
| Total Debt | 353.61 K | ||||
| Current Ratio | 0.39 X | ||||
| Cash Flow From Operations | (199.9 K) | ||||
| Beta | -269.78 | ||||
| Market Capitalization | 1.46 M | ||||
| Total Asset | 189.28 K | ||||
| Retained Earnings | (1.16 M) | ||||
| Net Asset | 189.28 K |
About Somatic Systems Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Somatic Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Somatic Systems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Somatic Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Total Revenue | 96.7 K | 98.6 K | |
| Cost Of Revenue | 11.2 K | 10.5 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Somatic Stock Analysis
When running Somatic Systems' price analysis, check to measure Somatic Systems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Somatic Systems is operating at the current time. Most of Somatic Systems' value examination focuses on studying past and present price action to predict the probability of Somatic Systems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Somatic Systems' price. Additionally, you may evaluate how the addition of Somatic Systems to your portfolios can decrease your overall portfolio volatility.